Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Clinical trial NCT06592924 · RECRUITING
Trial details
- NCT number
- NCT06592924
- Sponsor
- Canadian Cancer Trials Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-28
- Primary completion
- 2031-03-14
- Enrollment
- 830
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.